A novel method to investigate drug resistance in the chronic lymphocytic leukemia (CLL) microenvironment: Analysis of CLL Cellular Environment and Response (ACCER). Issue 4 (21st March 2023)

• Record Type: Journal Article
• Authors: Choquette, Tricia; Henson, Elizabeth S.; Yang, Xiaoyan; Johnston, James B.; Gibson, Spencer B.
• Is Part Of: Leukemia & lymphoma. Volume 64:Issue 4(2023)
• Page Start: 822
• Page End: 834
• Publication Date: 2023-03-21
• Subjects: Chemotherapeutic approaches -- drug resistance -- lymphoid leukemia; Leukemia -- Periodicals; Lymphomas -- Periodicals; 616.99419
• DOI: 10.1080/10428194.2023.2171729
• Languages: English
• ISSNs: 1042-8194

Abstract

Abstract: Microenvironments such as lymph nodes allow chronic lymphocytic leukemia (CLL) cells to survive and become drug resistant. There are limited methods to study the to study the contribution of the stromal microenvironment. We have adapted a solid tumor microenvironment cell culture system that provides elements of the CLL microenvironment called Analysis of CLL Cellular Environment and Response (ACCER). We optimized the cell number for patient's primary CLL cells and HS-5 human bone marrow stromal cell line that will give sufficient cell number and viability with the ACCER. We then determined the amount of collagen type 1 to give the best extracellular matrix to seed CLL cells to the membrane. Finally, we determined that ACCER provide CLL cell protection against cell death following treatment with fludarabine and ibrutinib compared to co-culture conditions. This describes novel microenvironment model to investigate factors that promote drug resistance in CLL.